Aurobindo Cipla News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Updated Jan 11, 2021 | 15:42 IST In an exclusive interaction with ET Now we spoke to GV Prasad, Co-chairman and Managing Director, at Dr Reddy's Laboratories. Screengrab  Nifty Pharma Index has given returns of 60% making it one of the best performing sectors for the first time since 2015. Nifty Pharma has gained nearly 4x vs Nifty in 2020 with Nifty being up nearly 15% in 2020. Since March 2020 low Pharma as an index is up 85%. From the lows of 2020, Pharma stocks like Aurobindo & Cipla are up >100%. Factoring in the run-up experts says Tailwinds are emerging in ...

Ravi Dharamshi, CIO, ValueQuest Investment Advisors who tracks pharma very closely says that Covid crisis acted as a catalyst for pharma stocks to rally but Indian pharma companies have more legs for growth across the region and the rally is not only related to Covid. He added that growth opportunity for Indian Pharma companies in the US is large with high growth areas like Biosimilars, Inhalers & Complex Molecules. He also said that API players in India are looking interesting at global giants look to source API from Indian Markets. Catch the Full Interview with Ravi Dharamshi CIO of ValueQu...